Assessing the Impact of Electronic Capture of Patient Reported Outcomes in Radiation Oncology

Patients With Lung, Breast, Head and Neck, or Pelvic Malignancies Clinical Trial

Official title:

Assessing the Impact of Electronic Capture of Patient Reported Outcomes in Radiation Oncology

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02756767
• Other study ID #: UPCC 24915
• Status: Completed
• Start date: April 2016
• Est. completion date: April 2021

Study information

• Verified date: June 2021
• Source: Abramson Cancer Center of the University of Pennsylvania
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The goals of this study are to assess the feasibility of weekly administration of site specific patient reported assessments using an electronic platform and to explore the correlation between patient reported outcomes as well as known dosimetric prognostic factors in patients with lung, breast, head and neck, or pelvic malignancies

Recruitment information / eligibility

• Status: Completed
• Enrollment: 75
• Est. completion date: April 2021
• Est. primary completion date: April 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patients with breast cancer, lung cancer, head and neck cancer, or gynecologic cancer receiving definitive external beam radiotherapy.

• Must be = 18 years of age

• Able to read, write, and speak English in order to complete patient reported outcomes.

Patients will be approached about the study at the time of consultation or at the time of simulation by their treating physicians or by a research coordinator. All patients must sign a study-specific informed consent to participate. All patients, including those who do not choose to consent to the study, will be provided with a short survey to assess health literacy using the eHealth Literacy Scale (eHEALS).

For those not consenting to the study, the survey will be de-identified and will also ask for basic demographic information including age grouping, race, education level, and type of cancer.

Related Conditions & MeSH terms

• Neoplasms
• Patients With Lung, Breast, Head and Neck, or Pelvic Malignancies

Intervention

Other:
• Survey

Locations

Country	Name	City	State
United States	Abramson Cancer Center of the University of Pennsylvania	Philadelphia	Pennsylvania

Sponsors (1)

Lead Sponsor	Collaborator
Abramson Cancer Center of the University of Pennsylvania

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of Surveys completed		five years